Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Study says Decidualization defects has direct relation to Preeclampsia - The Pharma Times | Pharma & Health Care News Portal

Study says Decidualization defects has direct relation to Preeclampsia

New Delhi, March 29, 2018: A scientific study led by father of genetics Dr. Carlos Simon has said that there is a connection between the changes in cells of the endometrium in preparation for, and during (decidualization) pregnancy is related to high blood pressure in pregnancy (preeclampsia).

  • Until now, research efforts to understand why preeclampsia occurs had been focused on studying the placenta.
  • Our study shows that a defect in the decidualization process of the endometrium may be one of the causes of preeclampsia.
  • It broadens the possibility of developing the early diagnosis of preeclampsia by identifying this decidualization defect.

Preeclampsia is a severe complication that occurs in the third trimester or 20 weeks of pregnancy, affecting around 8% of the total pregnant women.

If  not diagnosed on time, it may lead to significant complications with both the mother and foetus during the pregnancy. Until now, most research on the topic had focused on investigating defects in placenta formation that resulted in the onset of the disease, ignoring the role of the maternal uterine tissue where the embryo is implanted.

Our study shows the link between the onset of preeclampsia and a defect in the decidualization process in the endometrium. Decidualization is an endometrial process that entails preparing the uterus for the implantation of the embryo and a successful pregnancy. This defect not only occurs in the endometrium of women who have suffered from preeclampsia during a previous pregnancy, but also in patients who have preeclampsia at the time of birth.

This discovery offers an explanation as to why women with preeclampsia are more prone to a recurrence of this condition

in future pregnancies. This study paves the way towards developing a clinical diagnosis that facilitates the prospective risk assessment

of suffering from preeclampsia and the possible treatment of this condition before pregnancy.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

8 hours ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

2 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

1 week ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

2 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago